Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MLN3126 is an orally active, potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis in mouse primary thymocytes with an IC50 value of 6.3 nM for calcium influx inhibition.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 198,000 |
50 mg | 約6-8 週間 | ¥ 257,000 |
100 mg | 約6-8 週間 | ¥ 369,500 |
説明 | MLN3126 is an orally active, potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis in mouse primary thymocytes with an IC50 value of 6.3 nM for calcium influx inhibition. |
分子量 | 446.9 |
分子式 | C21H19ClN2O5S |
CAS No. | 628300-71-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MLN3126 628300-71-0 Inhibitor inhibitor inhibit